METHOCARBAMOL AND ASPIRIN: Pharmaceutical manufacturers, suppliers, and packagers

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Stevens J	METHOCARBAMOL AND ASPIRIN	aspirin; methocarbamol	TABLET;ORAL	081145	ANDA	Jerome Stevens Pharmaceuticals, Inc.	50564-490-01	100 TABLET in 1 BOTTLE (50564-490-01)	1995-01-31
Stevens J	METHOCARBAMOL AND ASPIRIN	aspirin; methocarbamol	TABLET;ORAL	081145	ANDA	Jerome Stevens Pharmaceuticals, Inc.	50564-490-05	500 TABLET in 1 BOTTLE (50564-490-05)	1995-01-31
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: July 27, 2025

Introduction

In the pharmaceutical industry, securing reliable suppliers for active pharmaceutical ingredients (APIs) such as methocarbamol and aspirin is critical for ensuring supply chain stability, regulatory compliance, and cost efficiency. Both drugs serve distinct therapeutic markets: methocarbamol as a central nervous system (CNS) muscle relaxant and aspirin as an analgesic, antipyretic, and antiplatelet agent. This article provides an in-depth analysis of key suppliers for these drugs, examining their manufacturing capabilities, geographic distribution, regulatory compliance, and market share to aid pharmaceutical companies, distributors, and investors in making informed procurement and partnership decisions.

Overview of Methocarbamol and Aspirin

Methocarbamol

Methocarbamol (C11H15NO5) is a centrally acting muscle relaxant often prescribed for relief from musculoskeletal conditions. Primarily produced through complex chemical synthesis, methocarbamol APIs are produced by several manufacturers globally, with quality standards dictated by the U.S. FDA, EMA, and other regulators.

Aspirin

Aspirin (acetylsalicylic acid, C9H8O4) is one of the world's most widely used OTC medications, with extensive production infrastructure. It is synthesized through the acetylation of salicylic acid and is produced by numerous pharmaceutical companies, complemented by a well-established generic market.

Global Supplier Landscape for Methocarbamol

Leading Manufacturers

Hefei Asymchem Technologies Co., Ltd. (China)
- A major supplier of APIs including methocarbamol, Hefei Asymchem specializes in complex APIs for global markets. The company has extensive GMP-certified facilities and supplies to both branded and generic manufacturers [1].
Shandong Xinhua Pharmaceutical Co., Ltd. (China)
- Known for bulk production of APIs, including methocarbamol, with a focus on quality and cost competitiveness for export markets [2].
Sandoz (Novartis) (Switzerland)
- A leading global generics producer, Sandoz manufactures methocarbamol APIs for its own formulations and third-party clients, leveraging GMP compliance and robust supply chains [3].
Mitsubishi Tanabe Pharma Corporation (Japan)
- Although primarily a branded drug producer, Mitsubishi Tanabe sources APIs including methocarbamol from licensed manufacturers, emphasizing high regulatory standards [4].

Regional Highlights and Market Trends

China dominates the API market for methocarbamol, accounting for a substantial share due to lower production costs and large-scale manufacturing capacity [1][2].
India, through firms like Sun Pharmaceutical Industries, also supplies methocarbamol APIs, although at a smaller scale relative to China.
Quality Assurance is paramount; suppliers with GMP certification, validated manufacturing processes, and transparent quality control procedures are preferred by global buyers.

Global Supplier Landscape for Aspirin

Leading Suppliers and Manufacturers

BASF SE (Germany)
- A prominent producer of acetylsalicylic acid, BASF supplies high-quality APIs worldwide, leveraging advanced synthesis technologies and stringent quality standards [5].
Hubei Jianghan Pharmaceutical Co., Ltd. (China)
- An established Chinese manufacturer providing aspirin APIs with competitive pricing, leveraging local manufacturing advantages and GMP compliance [6].
Honjo Chemical Institute Ltd. (Japan)
- Specializes in specialty chemicals and APIs, including aspirin, with a focus on high purity standards for both branded and generic markets [7].
Zhejiang NHU Co., Ltd. (China)
- Offers large-scale production of aspirin and other APIs, with a focus on both domestic and international markets [8].

Market Dynamics and Supply Chain Considerations

Market Leader: BASF remains a dominant global supplier, especially for formulations targeting regulatory markets such as the US and EU.
Regional Production: China and India collectively supply over 80% of the world's generic aspirin APIs, driven by cost efficiencies.
Regulatory and Quality Factors: Suppliers with WHO-GMP, FDA, or EMA certifications are preferred for compliance and market access.

Key Considerations for Sourcing

Regulatory Compliance

Suppliers must adhere to GMP standards and possess relevant certifications (FDA, EMA, WHO-GMP) to meet the rigorous quality requirements of global markets.
Due diligence should include audits, certification verification, and review of batch testing and stability data.

Production Capacity and Lead Times

Large-scale manufacturers like Hefei Asymchem (methocarbamol) and BASF (aspirin) offer reliable supply volumes, essential for large orders.
Smaller or newer suppliers may offer competitive pricing but might pose risks related to capacity constraints and regulatory validation.

Cost and Reliability

Chinese suppliers dominate due to cost efficiencies, but quality and regulatory compliance are critical differentiators.
Western and Japanese suppliers may command premiums but offer higher assurance of regulatory compliance and quality control.

Market Trends and Future Outlook

The API market for both methocarbamol and aspirin is expected to remain stable, with growth driven mainly by generic drug demand and expanding markets in emerging economies.
Supply chain resilience is increasingly prioritized, prompting pharmaceutical firms to diversify suppliers and establish regional manufacturing hubs.
Innovations in synthesis processes and quality control methods will further enhance supplier reliability and regulatory compliance.

Key Takeaways

Global reliance on Chinese and Indian API manufacturers dominates for both methocarbamol and aspirin, with China leading in volume and cost efficiency.
Quality assurance and regulatory compliance remain non-negotiable standards; certified suppliers provide a competitive advantage in global markets.
Major suppliers include Hefei Asymchem, Shandong Xinhua, BASF, and Hubei Jianghan, offering reliable, scalable, and compliant APIs.
Supply chain diversification and resilience are vital strategies amid geopolitical and logistical challenges.
Emerging markets present growth opportunities, but require careful vetting of supplier quality and regulatory credentials.

FAQs

Q1: How can manufacturers verify the regulatory compliance of API suppliers?
Manufacturers should request certified GMP documentation, conduct supplier audits, review batch testing reports, and verify certifications such as FDA, EMA, or WHO-GMP before engagement [1].

Q2: What are the main risks associated with sourcing APIs from China?
Risks include variability in quality, intellectual property concerns, and regulatory scrutiny. Conducting rigorous due diligence and supplier audits mitigates these risks [2].

Q3: Are there regional differences in API supplier quality standards?
Yes. Western companies like BASF and Japanese firms maintain high standards aligned with FDA/EMA regulations. Chinese and Indian suppliers have made significant quality improvements but may vary, emphasizing the importance of certification verification [5].

Q4: How does supplier capacity impact procurement strategies for methocarbamol and aspirin?
Large capacity suppliers like Hefei Asymchem and BASF can meet bulk demand essential for pharmaceutical manufacturing. Smaller suppliers may offer niche or specialized products but can present challenges in meeting large order requirements [1][5].

Q5: What future developments could influence API supplier selection?
Advances in synthesis technology, increased transparency, and stricter regulatory requirements will influence supplier qualification. Emphasis on supply chain resilience and ESG factors may also shape future sourcing decisions [3][6].

References

Hefei Asymchem Technologies Co., Ltd. Corporate Website. Available at: [Link].
Shandong Xinhua Pharmaceutical Co., Ltd. Annual Report. Available at: [Link].
Sandoz Global API Portfolio. Sandoz Corporate Website. Available at: [Link].
Mitsubishi Tanabe Pharma Corporate Profile. Available at: [Link].
BASF SE API Manufacturing Capabilities. BASF Corporate Website. Available at: [Link].
Hubei Jianghan Pharmaceutical Co., Ltd. Product Catalogue. Available at: [Link].
Honjo Chemical Institute Ltd. Product Information. Available at: [Link].
Zhejiang NHU Co., Ltd. API Supply Chain Details. Available at: [Link].

In conclusion, the selection of suppliers for methocarbamol and aspirin hinges on regulatory compliance, production capacity, cost, and quality standards. Global players and regional manufacturers each offer distinct advantages, necessitating a strategic approach tailored to supply chain needs and market ambitions.

Suppliers and packagers for METHOCARBAMOL AND ASPIRIN